Vesa Manninen

发表

Ion and water shifts produced by ammonium chloride in high K and low K red cells

S. Salminen, Vesa Manninen, 1966, Journal of cellular physiology.

Endothelium‐dependent and ‐independent effects of exogenous ATP, adenosine, GTP and guanosine on vascular tone and cyclic nucleotide accumulation of rat mesenteric artery

H. Vapaatalo, I. Pörsti, P. Vuorinen, 1992, British journal of pharmacology.

Clinical and lipid metabolic effects of unopposed oestrogen and two oestrogen-progestogen regimens in post-menopausal women.

V. Manninen, M. Mälkönen, J. Kärkkäinen, 1987, Maturitas.

Some coronary risk factors related to the insulin resistance syndrome and treatment with gemfibrozil. Experience from the Helsinki Heart Study.

L. Tenkanen, V. Manninen, M. Mänttäri, 1995, Circulation.

Prediction of myocardial infarction in dyslipidemic men by elevated levels of immunoglobulin classes A, E, and G, but not M.

P. Kovanen, V. Manninen, K. Aho, 1998, Archives of internal medicine.

Serum ferritin and ceruloplasmin as coronary risk factors.

J. Huttunen, C. Ehnholm, M. Frick, 1994, European heart journal.

Infections, inflammation, and the risk of coronary heart disease.

M. Leinonen, P. Saikku, L. Tenkanen, 2000, Circulation.

Apolipoprotein E polymorphism influences the serum cholesterol response to dietary intervention.

J. Huttunen, C. Ehnholm, P. Koskinen, 1991, Metabolism: clinical and experimental.

The Helsinki Heart Study: an 8.5‐year safety and mortality follow‐up

J. Huttunen, M. Frick, O. Heinonen, 1994, Journal of internal medicine.

The Helsinki Heart Study: central findings and clinical implications.

J. Huttunen, L. Tenkanen, M. Frick, 1991, Annals of medicine.

A study to determine the response of coronary atherosclerosis to raising low high density lipoprotein cholesterol with a fibric-acid derivative in men after coronary bypass surgery. The rationale, design, and baseline characteristics of the LOCAT Study. Lopid Coronary Angiography Trial.

Nieminen, M. Nieminen, M. Taskinen, 1997, Controlled clinical trials.

Adrenal androgens and testosterone as coronary risk factors in the Helsinki Heart Study.

H. Adlercreutz, J. Huttunen, L. Tenkanen, 1994, Atherosclerosis.

Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants.

J. Huttunen, M. Jauhiainen, C. Ehnholm, 1991, Atherosclerosis.

Relation between QT intervals and heart rates from 40 to 120 beats/min in rest electrocardiograms of men and a simple method to adjust QT interval values.

J. Karjalainen, M. Viitasalo, V. Manninen, 1994, Journal of the American College of Cardiology.

Joint effects of C-reactive protein and other risk factors on acute coronary events.

L. Tenkanen, O. Vaarala, V. Manninen, 2001, American heart journal.

Antibody against oxidized low-density lipoprotein predicting myocardial infarction.

L. Tenkanen, C. Ehnholm, G. Alfthan, 1994, Archives of internal medicine.

How to define coronary heart disease in register-based follow-up studies: experience from the Helsinki Heart Study.

L. Tenkanen, K. Pietilä, V. Manninen, 1997, Annals of medicine.

Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men.

L. Tenkanen, O. Vaarala, M. Puurunen, 1995, Circulation.

Medication compliance and serum lipid changes in the Helsinki Heart Study.

O. Heinonen, V. Manninen, O. Heinonen, 1991, British journal of clinical pharmacology.

Reduction in Q wave myocardial infarctions with gemfibrozil in the Helsinki Heart Study.

J. Huttunen, M. Frick, O. Heinonen, 1990, American heart journal.

Efficacy of gemfibrozil in dyslipidaemic subjects with suspected heart disease. An ancillary study in the Helsinki Heart Study frame population.

J. Huttunen, M. Frick, O. Heinonen, 1993, Annals of medicine.

Relation between baseline lipid and lipoprotein values and the incidence of coronary heart disease in the Helsinki Heart Study.

J. Huttunen, L. Tenkanen, M. Frick, 1989, The American journal of cardiology.

Effect of gemfibrozil on the concentration and composition of serum lipoproteins. A controlled study with special reference to initial triglyceride levels.

J. Huttunen, M. Frick, P. Koskinen, 1990, Atherosclerosis.

The Helsinki Heart Study: basic design and randomization procedure.

J. Huttunen, M. Frick, O. Heinonen, 1987, European heart journal.

Altered absorption of digoxin in patients given propantheline and metoclopramide.

V. Manninen, M. Karesoja, A. Apajalahti, 1973, Lancet.

The triglyceride issue revisited. Findings from the Helsinki Heart Study.

L. Tenkanen, K. Pietilä, V. Manninen, 1994, Archives of internal medicine.

Alcohol and coronary heart disease: the roles of HDL‐cholesterol and smoking

L. Tenkanen, V. Manninen, M. Mänttäri, 1997, Journal of internal medicine.

Gemfibrozil also corrects dyslipidemia in postmenopausal women and smokers.

J. Tuomilehto, P. Kovanen, P. Koskinen, 1992, Archives of internal medicine.

Compliance with medication in the helsinki heart study

O. Heinonen, V. Manninen, H. Mäenpää, 2004, European Journal of Clinical Pharmacology.

Gemfibrozil in the treatment of dyslipidaemia. A 5-year follow-up study.

J. Tuomilehto, J. Virtamo, V. Manninen, 2009, Acta medica Scandinavica. Supplementum.

Clinical results with gemfibrozil and background to the Helsinki Heart Study.

V. Manninen, Vesa Manninen, 1983, The American journal of cardiology.